Ozempic and Cancer Risk — What We Know Titelbild

Ozempic and Cancer Risk — What We Know

Ozempic and Cancer Risk — What We Know

Von: Inception Point Ai
Jetzt kostenlos hören, ohne Abo

Über diesen Titel

 Could GLP-1 drugs like Ozempic increase cancer risk—or prevent it? Dr. Ben Synth cuts through contradictory headlines to examine thyroid warnings, surprising protective effects against obesity-related cancers, and how to interpret conflicting medical evidence. Learn what the science actually shows about these blockbuster medications and cancer.

For more content like this, visit QuietPlease.aiCopyright 2025 Inception Point Ai
Folgen
  • Ozempic and Cancer Risk — What We Know - The Plot Twist

    Ozempic and Cancer Risk — What We Know - The Plot Twist
    Apr 7 2026
    Host Ben Synth explores how GLP-1 drugs like Ozempic, which carry thyroid cancer warnings from rodent studies, are showing unexpected cancer-protective effects in humans. New research reveals colon cancer patients on these medications have half the mortality rate, while studies show reduced risk across twelve obesity-related cancers—challenging assumptions about these widely-prescribed medications.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    26 Min.
Noch keine Rezensionen vorhanden